Company news
Braxia Scientific Corp news in 2023
Braxia Scientific Corp's news releases, calls and decks from 2023, newest first.
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update
November 30, 2023
Braxia Scientific Reports Q1 Fiscal 2024 Financial Results
August 30, 2023
Braxia Scientific Reports Fiscal 2023 Financial Results
July 31, 2023
RETRANSMISSION: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic
June 12, 2023
Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic
June 9, 2023
Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP
March 16, 2023
Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals
March 1, 2023
Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement
February 27, 2023
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals
February 7, 2023
Braxia Scientific Announces Offering up to $1.5 Million, Braxia Management to Participate in Concurrent Private Placement
February 7, 2023
RETRANSMISSION: Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
January 30, 2023
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
January 27, 2023
Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.
January 10, 2023